Non-State Actors and Public Health Emergencies
By Rossella De Falco Strong, well-coordinated and resilient public health care services play a vital role in preventing and responding to public health crises. Under international human rights law,...
View ArticleKey Considerations for Patient-Reported Outcome Measures
By Sharona Hoffman Patient-reported outcome measures (PROMs) are questionnaires that patients fill out on tablets or other computers or devices. They ask patients to check boxes in answer to questions...
View ArticleHuman Rights Principles in Public Health Emergencies: From the Siracusa...
By Eric A. Friedman and Lawrence O. Gostin In 1984, the United Nations Economic and Social Council (ECOSOC) adopted the Siracusa Principles, which state that restrictions on human rights must meet...
View ArticleWant to Change Minds About Psychedelics? Start with PTSD
By Vincent Joralemon Psychedelics have a public relations problem, due in part to overzealous promoters, genuine risks, and bad science. But, recent psychedelic legislation sponsored by conservative...
View ArticleReflections on the United States Health Care System and the Right to Health
By Brianna da Silva Bhatia, Michele Heisler, and Christian De Vos American health care too often fails to protect the right to health or promote health-related rights. Despite efforts to increase...
View ArticleReviewing Solidarity in the Principles and Guidelines on Human Rights and...
By Eduardo Arenas Catalán The Principles and Guidelines on Human Rights and Public Health Emergencies (the Principles), entail a notable attempt to consolidate lessons learned from the COVID-19...
View ArticleOld Dogs and New Tricks: A Case for the Principles and Guidelines on Human...
By Nerima Were and Allan Maleche Taking into account our experiences as human rights lawyers working in Kenya during the COVID-19 pandemic, in this article we briefly analyze the Principles and...
View ArticleWhat’s on the Horizon for Health and Biotech with the AI Executive Order
By Adithi Iyer Last month, President Biden signed an Executive Order mobilizing an all-hands-on-deck approach to the cross-sector regulation of artificial intelligence (AI). One such sector (mentioned,...
View ArticleJudging in the Pandemic – A Malawian Perspective
By Zione Ntaba Malawi is not a stranger to public health crises in the last number of years, having faced a severe HIV epidemic and several cholera outbreaks continuing into 2023. Nevertheless, the...
View ArticleKetamine is the New Viagra
By Vincent Joralemon Spravato, the first FDA-approved psychedelic therapy, just outsold Viagra. Johnson & Johnson’s ketamine-based formulation generated $183 million in Q3, surpassing Pfizer’s...
View ArticlePublic Health Emergencies and Human Rights Principles: A Solidarity Approach
By Anne Kjersti Befring and Cecilia Marcela Bailliet Introduction The COVID-19 pandemic posed a grave threat to humanity and revealed the need for a new approach to improve transnational cooperation...
View ArticleDon’t Be Too Alarmed by the New SCOTUS Antibody Ruling
Amgen v. Sanofi is an important case, but it won’t transform patent law on its own. By Timothy Bonis Last April, the Supreme Court ruled in Amgen v. Sanofi, a closely watched patent case where the...
View ArticleThe SCOTUS Antibody Ruling Has an Uncertain Impact for Drug Makers and Patients
How Amgen v. Sanofi will affect innovation and the pharmaceutical industry. By Timothy Bonis Millions of patients rely on monoclonal antibodies. The global market in 2022 was $210B with a compound...
View ArticleClimate Change and Neglected Tropical Diseases: Key Takeaways from the...
By Aparajita Lath* The World Health Organization (WHO), in collaboration with the World Intellectual Property Organization (WIPO) and the World Trade Organization (WTO), hosted the 10th Trilateral...
View ArticleConclusion to the Symposium: From Principles to Practice: Human Rights and...
By Timothy Fish Hodgson, Roojin Habibi, and Alicia Ely Yamin In developing the digital symposium, From Principles to Practice: Human Rights and Public Health Emergencies (which ran from October –...
View ArticleAI, Copyright, and Open Science: Health Implications of the New York...
By Adithi Iyer The legal world is atwitter with the developing artificial intelligence (“AI”) copyright cage match between The New York Times and OpenAI. The Times filed its complaint in Manhattan...
View ArticleClik here to view.
Introductory Editorial — Critical Psychedelic Studies: Correcting the Hype
By Neşe Devenot Since the 2022 publication of “Preparing for the Bursting of the Psychedelic Hype Bubble,” a JAMA Psychiatry Viewpoint by David Yaden and colleagues, a wave of scholarship and...
View ArticlePsychedelics in the Clinical Setting: The Potential for Harm and the Promise...
By Caroline Hayes The psychedelic renaissance is well underway, with hundreds of clinical trials currently looking into a plethora of different mental health conditions. I was a sub-investigator on a...
View ArticleThe Psychedelics Industry: Psychedelic Evangelism in Second Wave Research
By Patric Plesa As interest in psychedelics research and popular psychedelics culture resurges, it is becoming progressively more difficult to discern facts from fantasy. As an academic with expertise...
View ArticleHistory Rhymes with the Psychedelic Boom
By David Herzberg As a historian of psychoactive pharmaceuticals in the 20th century U.S., I see history rhyming in potentially dangerous ways in the current psychedelic boom. After decades of being...
View Article
